One Weight Loss Strategy Is 5x More Effective Than Ozempic, Study Finds
ScienceAlert••health
Key Points:
- A study by New York University compared weight loss outcomes of bariatric surgeries (sleeve gastrectomy and gastric bypass) with GLP-1 receptor agonist drugs like semaglutide and tirzepatide, finding surgery led to significantly greater weight loss over two years (25.7% vs. 5.3%).
- The difference in effectiveness is partly due to lower adherence to GLP-1 medications, with up to 70% of patients discontinuing treatment within a year, whereas surgery offers a more permanent solution.
- Although GLP-1 drugs show beneficial effects, including blood sugar control and reduced risks of cancer and cardiovascular disease, bariatric surgery was associated with even better blood sugar management in the study.
